ANIMALCARE GROUP PLC Logo

ANIMALCARE GROUP PLC

Develops and commercializes veterinary pharmaceutical products and services globally.

ANCR | IL

Overview

Corporate Details

ISIN(s):
GB0032350695
LEI:
213800A7XPQ528RMCC72
Country:
United Kingdom
Address:
MOORSIDE, YO32 9LB YORK

Description

Animalcare Group PLC is an international veterinary sales and marketing organization focused on improving animal health and wellbeing. The company develops, sources, and commercializes a range of veterinary pharmaceutical products and services designed to support the veterinary profession. Its growth strategy centers on bringing innovative products to market through a combination of its internal development pipeline, strategic partnerships, acquisitions, and the in-licensing of early and late-stage products. The company maintains a direct commercial presence in several European countries and exports to numerous markets globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-06-10 17:41
Second Price Monitoring Extn
English 2.8 KB
2021-06-10 17:35
Price Monitoring Extension
English 2.8 KB
2021-06-09 18:03
Result of 2021 AGM
English 8.3 KB
2021-05-17 08:00
Annual Report 2020 and Notice of AGM
English 8.7 KB
2021-04-22 08:00
Daxocox approved by EU and UK authorities
English 14.0 KB
2021-03-30 08:00
Full Year Results 2020
English 378.9 KB
2021-03-23 08:00
Notification of major holding
English 46.2 KB
2021-02-18 17:36
Price Monitoring Extension
English 2.8 KB
2021-02-18 16:43
Daxocox receives positive opinion from CVMP in EU
English 9.2 KB
2021-02-08 15:46
Notification of major holding
English 46.9 KB
2021-02-01 08:00
Appointment of Nominated Advisor and Joint Broker
English 8.7 KB
2021-01-21 08:00
Trading Update and Notice of Full Year Results
English 9.6 KB
2020-11-18 08:00
Grant of options
English 27.5 KB
2020-09-29 08:00
Interim Results H1 2020
English 293.5 KB
2020-09-28 08:00
Animalcare and Kane Biotech to target biofilms
English 15.0 KB

Automate Your Workflow. Get a real-time feed of all ANIMALCARE GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ANIMALCARE GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ANIMALCARE GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.